Essential Reads: More Data on ADHD Medications and Pregnancy
Women with attention-deficit/hyperactivity disorder (ADHD) often discontinue psychostimulant medications during pregnancy, especially if they have milder symptoms. While this approach makes sense in terms of limiting unnecessary exposures in women with what appears to be milder illness, we have often been surprised by clinical outcomes in this population, specifically [...]
Taking a Closer Look at Motor Development in Children with Prenatal Exposure to Antidepressants
While we have data to support the use of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin norepinephrine reuptake inhibitors (SNRIs), during pregnancy, most studies have focused on risk of congenital malformations, and we have considerably less information on longer term neurodevelopmental outcomes. A new study [...]
Weekly Roundup for JANUARY 15, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. Galbally and colleagues look at the motor development of children exposed to [...]
Essential Reads: Is there a Role for Omega-3 Fatty Acids in Women at Risk for Perinatal Depression?
The omega-3 polyunsaturated fatty acids (PUFAs), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential components of the human diet and have a broad range of health benefits. Furthermore, they may also be beneficial for the treatment of mood disorders. Outside of the perinatal period, several studies have demonstrated [...]